The goal of this study is to compare the efficacy of a dynamic compression device (DDS) with traditional multicomponent bandages (TMCB) in terms of excess volume reduction in lower limb lymphoedema during the first 5 days of intensive treatment.
Participants in both groups will undergo the standard decongestive treatment protocol of the trial site. The only difference between both groups will be the modality of the compression therapy:
* the intervention (DDS) group will wear the compression 24/24 during the first 5 days of intensive treatment
* the control group will wear TMCB 24/24 during the first 5 days of intensive treatment (i.e. the standard treatment)